Insider · CIK 0001824862

Anderson Kenneth Carl

Reports to the SEC for 1 company · WATERTOWN, MA

sec.gov

Transactions

Companies

Filings

CIK

0001824862

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-01	CCCCC4 Therapeutics, Inc.A Award	Director	AAward	+3,662 sh	$3.14	+$11.5K	75,612
2026-07-01	CCCCC4 Therapeutics, Inc.A Award	Director	AAward	+2,650 sh	$4.34	+$11.5K	71,950
2026-06-24	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+62K sh	—	—	62,000
2026-06-01	CCCCC4 Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,070 sh	$2.11	+$2,257.7	69,300
2026-06-01	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,070 sh	—	—	0
2026-04-01	CCCCC4 Therapeutics, Inc.A Award	Director	AAward	+4,259 sh	$2.70	+$11.5K	68,230
2026-01-02	CCCCC4 Therapeutics, Inc.A Award	Director	AAward	+5,958 sh	$1.93	+$11.5K	146,532
2025-10-01	CCCCC4 Therapeutics, Inc.A Award	Director	AAward	+5,349 sh	$2.15	+$11.5K	140,574
2025-07-01	CCCCC4 Therapeutics, Inc.A Award	Director	AAward	+7,616 sh	$1.51	+$11.5K	135,225
2025-06-18	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+35.5K sh	—	—	35,500
2025-04-01	CCCCC4 Therapeutics, Inc.A Award	Director	AAward	+7,841 sh	$1.44	+$11.3K	127,609
2025-01-02	CCCCC4 Therapeutics, Inc.A Award	Director	AAward	+3,074 sh	$3.66	+$11.3K	119,768
2024-10-01	CCCCC4 Therapeutics, Inc.A Award	Director	AAward	+2,023 sh	$5.56	+$11.2K	116,694
2024-07-01	CCCCC4 Therapeutics, Inc.A Award	Director	AAward	+2,320 sh	$4.85	+$11.3K	114,671
2024-06-20	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+32.5K sh	—	—	32,500
2024-04-01	CCCCC4 Therapeutics, Inc.A Award	Director	AAward	+1,389 sh	$8.10	+$11.3K	112,351
2024-01-02	CCCCC4 Therapeutics, Inc.A Award	Director	AAward	+1,725 sh	$6.52	+$11.2K	110,962
2023-10-02	CCCCC4 Therapeutics, Inc.A Award	Director	AAward	+6,617 sh	$1.70	+$11.2K	109,237
2023-07-03	CCCCC4 Therapeutics, Inc.A Award	Director	AAward	+3,976 sh	$2.83	+$11.3K	102,620
2023-06-15	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+26K sh	—	—	26,000
2023-04-03	CCCCC4 Therapeutics, Inc.A Award	Director	AAward	+3,516 sh	$3.20	+$11.3K	98,644
2023-01-06	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−268 sh	—	—	1,067
2023-01-06	CCCCC4 Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+268 sh	$2.11	+$565.48	94,684
2023-01-06	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−444 sh	—	—	890
2023-01-06	CCCCC4 Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+444 sh	$4.98	+$2,211.12	95,128
2023-01-03	CCCCC4 Therapeutics, Inc.A Award	Director	AAward	+1,568 sh	$6.38	+$10K	94,416
2022-10-03	CCCCC4 Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+445 sh	$4.98	+$2,216.1	91,698
2022-10-03	CCCCC4 Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+267 sh	$2.11	+$563.37	91,253
2022-10-03	CCCCC4 Therapeutics, Inc.A Award	Director	AAward	+1,150 sh	$8.69	+$9,993.5	92,848
2022-10-03	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−267 sh	—	—	1,335
2022-10-03	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−445 sh	—	—	1,334
2022-07-15	CCCCC4 Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+889 sh	$4.98	+$4,427.22	90,986
2022-07-15	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−535 sh	—	—	1,602
2022-07-15	CCCCC4 Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+535 sh	$2.11	+$1,128.85	90,097
2022-07-15	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−889 sh	—	—	1,779
2022-07-01	CCCCC4 Therapeutics, Inc.A Award	Director	AAward	+1,246 sh	$8.03	+$10K	89,562
2022-06-22	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+23.5K sh	—	—	23,500
2022-04-04	CCCCC4 Therapeutics, Inc.A Award	Director	AAward	+341 sh	$26.46	+$9,022.86	88,316
2022-01-26	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−803 sh	—	—	2,137
2022-01-26	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,334 sh	—	—	2,668
2022-01-26	CCCCC4 Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+803 sh	$2.11	+$1,694.33	86,641
2022-01-26	CCCCC4 Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,334 sh	$4.98	+$6,643.32	87,975
2022-01-04	CCCCC4 Therapeutics, Inc.A Award	Director	AAward	+278 sh	$31.58	+$8,779.24	85,838
2021-10-04	CCCCC4 Therapeutics, Inc.A Award	Director	AAward	+194 sh	$44.99	+$8,728.06	85,560
2021-07-02	CCCCC4 Therapeutics, Inc.A Award	Director	AAward	+220 sh	$39.72	+$8,738.4	85,366
2021-06-15	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+23.5K sh	—	—	23,500
2021-04-14	CCCCC4 Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+444 sh	$4.98	+$2,211.12	85,146
2021-04-14	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−444 sh	—	—	4,002
2021-04-14	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−267 sh	—	—	2,940
2021-04-14	CCCCC4 Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+267 sh	$2.11	+$563.37	84,702

Recent filings

Accepted (ET)
Oct 24
Anderson Kenneth Carl0001470831-26-000925
SEC(opens sec.gov)
Jul 24
Anderson Kenneth Carl0001470831-26-000688
SEC(opens sec.gov)
Jun 264
Anderson Kenneth Carl0001470831-26-000665
SEC(opens sec.gov)
Jun 44
Anderson Kenneth Carl0001470831-26-000504
SEC(opens sec.gov)
Apr 34
Anderson Kenneth Carl0001470831-26-000346
SEC(opens sec.gov)
Jan 54
Anderson Kenneth Carl0001470831-26-000009
SEC(opens sec.gov)
Oct 34
Anderson Kenneth Carl0001470831-25-000250
SEC(opens sec.gov)
Jul 24
Anderson Kenneth Carl0001662579-25-000053
SEC(opens sec.gov)
Jun 204
Anderson Kenneth Carl0001662579-25-000046
SEC(opens sec.gov)
Apr 34
Anderson Kenneth Carl0001662579-25-000024
SEC(opens sec.gov)
Jan 34
Anderson Kenneth Carl0001662579-25-000003
SEC(opens sec.gov)
Oct 24
Anderson Kenneth Carl0001662579-24-000089
SEC(opens sec.gov)
Jul 24
Anderson Kenneth Carl0001662579-24-000063
SEC(opens sec.gov)
Jun 214
Anderson Kenneth Carl0001662579-24-000055
SEC(opens sec.gov)
Apr 24
Anderson Kenneth Carl0001662579-24-000038
SEC(opens sec.gov)
Jan 34
Anderson Kenneth Carl0001662579-24-000005
SEC(opens sec.gov)
Oct 34
Anderson Kenneth Carl0001662579-23-000109
SEC(opens sec.gov)
Jul 54
Anderson Kenneth Carl0001662579-23-000068
SEC(opens sec.gov)
Jun 164
Anderson Kenneth Carl0001662579-23-000062
SEC(opens sec.gov)

Companies

C4 Therapeutics, Inc.DirectorCCCC

Address

C/O C4 THERAPEUTICS, INC. 490 ARSENAL WAY #120

WATERTOWN, MA, 02472